Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Jul 10, 2025, 4:00 PM
1.360
+0.020 (1.49%)
After-hours: Jul 10, 2025, 6:02 PM EDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $31.74 million as of July 10, 2025. Its market cap has increased by 23.98% in one year.
Market Cap
31.74M
Enterprise Value
11.69M
1-Year Change
23.98%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $31.74M, a decrease of -65.76%. That is a compound annual growth rate of -9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 31.00M | 20.62% |
| Dec 31, 2024 | 25.70M | -48.80% |
| Dec 29, 2023 | 50.20M | -30.76% |
| Dec 30, 2022 | 72.50M | -36.74% |
| Dec 31, 2021 | 114.60M | 31.57% |
| Dec 31, 2020 | 87.10M | 2,388.57% |
| Dec 31, 2019 | 3.50M | 34.62% |
| Dec 31, 2018 | 2.60M | -65.33% |
| Dec 29, 2017 | 7.50M | -49.32% |
| Dec 30, 2016 | 14.80M | -73.14% |
| Dec 31, 2015 | 55.10M | -33.69% |
| Dec 31, 2014 | 83.10M | -10.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |